Auriga Downgrades Salix Pharmaceuticals (SLXP) to Hold
Tweet
Share
E-mailGet Alerts SLXP Hot Sheet
Price: $172.81 --0%
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
Auriga downgraded Salix Pharmaceuticals (NASDAQ: SLXP) from Buy to Hold, price target lowered from $54 to $51.
For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.
Shares of Salix Pharmaceuticals closed at $50.01 yesterday.
For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.
Shares of Salix Pharmaceuticals closed at $50.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acrivon Therapeutics Inc (ACRV) PT Lowered to $22 at Jones Trading
- Nippon Life India Asset Management Ltd (NAM:IN) PT Raised to INR665 at HSBC
- Hitachi Construction Machinery Co Ltd (6305:JP) (HTCMY) PT Raised to JPY5,250 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
